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LETTERS TO THE EDITOR 
Influence of perfusion technique and pH 
management strategy during coronary artery 
bypass surgery 
To the Editor." 
In a "double-blind," randomized study of 316 patients, 
which compared two methods of perfusion techniques 
(nonpulsatile vs pulsatile) and pH management (alpha- 
stat versus pH-stat), Murkin and colleagues I report that 
pulsatile perfusion resulted in a highly significant reduc- 
tion in myocardial infarction, death, the need for an 
intraaortic balloon pump, and major complications. These 
dramatic conclusions are significantly flawed, however, 
both by fundamental limitations in the study design and by 
the particularly high mortality and morbidity in the non- 
pulsatile group: 
The operations were performed by four surgeons, two 
of whom used crystalloid cardioplegia nd two of whom 
used blood cardioplegia (we are not told of the route of 
administration of the latter). The fact that the four 
surgeons performed 94, 99, 21, and 102 operations intro- 
duces a further major difference between the groups, 
because simple calculation reveals that between 36% and 
39% of patients must have received one type of cardio- 
plegia and 64% to 61% of patients the other. To compli- 
cate matters even further, the surgeons using crystalloid 
cardioplegia performed significantly more grafts with sig- 
nificantly shorter crossclamp times (by approximately 20 
minutes) than those using blood cardioplegia. Despite the 
highly significant differences in cardioplegic techniques, 
number of grafts, and duration of ischemia in the two 
groups, which are all major independent determinants of
cardiac morbidity, the authors merely state, without pro- 
viding any objective data, that "eardioplegia type did not 
correlate with adverse outcome." 
The use of the term "double-blind" in the abstract is 
totally misleading. The four operating surgeons must have 
been aware both of the mode of perfusion (by observation 
of analog displays of arterial pulse pressure) and the type 
of cardioplegic solution administered. If so, it is conceiv- 
able that individual surgeons were influenced, albeit sub- 
consciously, in the number of grafts they performed (as 
indeed was the case for surgeons using crystalloid cardio- 
plegia) or the need for an intraaortic balloon pump. The 
fact that the research nurse and technician were blinded 
to the mode of perfusion is irrelevant with regard to the 
collection of objective data such as the number of patients 
who died, who had electrocardiographicaIly confirmed 
infarcts, or who required intraaortic balloon pumps. 
A further major concern in this study is the particularly 
high mortality and morbidity in the nonpulsatile group 
considering their favorable demographic features (their 
mean age was 61 years, and 95% had a left ventricular 
ejection fraction >35%). A mortality of 6% and a require- 
ment for an intraaortic balloon pump in 7% of such 
good-risk elective patients appears particularly excessive 
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and is unlikely to be simply explained by the use of 
nonpulsatile perfusion. 
Although the authors are to be congratulated on un- 
dertaking a potentially important clinical trial, major 
reservations regarding their conclusions must remain until 
objective data are presented to eliminate the effects of 
different surgeons, cardioplegic techniques, number of 
grafts, and ischemic times on postoperative cardiac mor- 
tality and morbidity. Furthermore, the possibility that the 
apparent benefit of pulsatile perfusion was simply due to 
an excessively high mortality in the nonpulsatile group for 
some other reason must remain a genuine concern. 
David P. Taggart, MD(Hons), FRCS 
Oxford Heart Centre 
John Radcliffe Hospital 
Headington 
Oxford OX3 9DU, United Kingdom 
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Reply to the Editor: 
On behalf of my coauthors I would like to thank Dr. 
Taggart for his insightful analysis of our paper "A Ran- 
domized Study of the Influence of Perfusion Technique 
and pH Management S rategy in 316 Patients Undergoing 
Coronary Bypass Surgery. I. Mortality and Cardiovascular 
Morbidity." He has identified a number of contentious 
issues regarding the study design, and he raises concern 
regarding overall morbidity and mortality rates in the 
nonpulsatile group. 
With regard to study design, we agree with Dr. Taggart 
that the very real differences in composition of cardiople- 
gic solutions, route of administration (one surgeon used 
blood cardioplegia administered retrogradely, n = 21; the 
other three administered the cardioplegic solution antero- 
gradely), number of grafts, and duration of crossclamp 
between cardioplegia types (blood versus crystalloid), if 
controlled for, might be expected to result in differences in 
outcome across cardioplegia groups. It is precisely be- 
cause of these many uncontrolled variables, however, that 
cardioplegic type was not significant in outcome (page 
343: death, myocardial infarction, arrhythmia, and inser- 
tion of an intraaortic balloon pump vs cardioplegia type, 
univariate analysis, p = 0.11). More grafts and shorter 
crossclamp times were associated with use of crystalloid 
cardioplegia. Usage of blood cardioplegia was associated 
with the converse, but presumably enabled a longer 
